title: B cell signature contributes to the prediction of RA development in patients with arthralgia.
authors.affiliation: Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Joyce
authors.initials: J
authors.lastname: Lübbers
authors.affiliation: Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Saskia
authors.initials: S
authors.lastname: Vosslamber
authors.affiliation: Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands.
authors.forename: Lotte A
authors.initials: LA
authors.lastname: van de Stadt
authors.affiliation: Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands.
authors.forename: Marian
authors.initials: M
authors.lastname: van Beers-Tas
authors.affiliation: Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: John G
authors.initials: JG
authors.lastname: Wesseling
authors.affiliation: Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: B Mary E
authors.initials: BM
authors.lastname: von Blomberg
authors.affiliation: Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Birgit I
authors.initials: BI
authors.lastname: Witte
authors.affiliation: Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Hetty J
authors.initials: HJ
authors.lastname: Bontkes
authors.affiliation: Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Clinical Immunology and Rheumatology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: Dirkjan
authors.initials: D
authors.lastname: van Schaardenburg
authors.affiliation: Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Cornelis L
authors.initials: CL
authors.lastname: Verweij
mesh_terms: D018941:Antigens, CD19 / Q000378:metabolism; D018951:Antigens, CD20 / Q000378:metabolism; D018771:Arthralgia / Q000276:immunology* / Q000378:metabolism; D001172:Arthritis, Rheumatoid / Q000276:immunology* / Q000378:metabolism; D001323:Autoantibodies / Q000276:immunology; D001402:B-Lymphocytes / Q000378:metabolism*; D051925:CD79 Antigens / Q000378:metabolism; D003661:Decision Support Techniques; D018450:Disease Progression; D006801:Humans; D007370:Interferon Type I / Q000276:immunology; D010456:Peptides, Cyclic / Q000276:immunology; D011379:Prognosis; D016016:Proportional Hazards Models; D012217:Rheumatoid Factor / Q000276:immunology
chemical_list: D018941:Antigens, CD19; D018951:Antigens, CD20; D001323:Autoantibodies; D051925:CD79 Antigens; C497881:CD79A protein, human; C497883:CD79B protein, human; D007370:Interferon Type I; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide; D012217:Rheumatoid Factor